PUTNAM INVESTMENTS LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,154,163
+16.6%
778,0000.0%0.00%
+100.0%
Q2 2023$990,005
-5.1%
778,0000.0%0.00%
-50.0%
Q1 2023$1,043,687
-14.9%
778,0000.0%0.00%0.0%
Q4 2022$1,226,517
-4.0%
778,000
-14.6%
0.00%0.0%
Q3 2022$1,278,000
+6.5%
911,0000.0%0.00%0.0%
Q2 2022$1,200,000
-8.4%
911,000
-8.9%
0.00%0.0%
Q1 2022$1,310,000
+5.1%
1,000,0000.0%0.00%0.0%
Q4 2021$1,247,000
-34.3%
1,000,000
-30.2%
0.00%
-33.3%
Q3 2021$1,899,000
-0.8%
1,432,0000.0%0.00%0.0%
Q2 2021$1,914,000
-10.7%
1,432,000
-10.2%
0.00%
-25.0%
Q1 2021$2,143,000
-10.5%
1,594,000
-8.1%
0.00%0.0%
Q4 2020$2,394,000
-56.2%
1,735,000
-56.4%
0.00%
-63.6%
Q3 2020$5,472,000
-23.3%
3,980,000
-7.2%
0.01%
-26.7%
Q2 2020$7,130,000
+46.2%
4,288,000
+12.3%
0.02%
+15.4%
Q1 2020$4,876,000
-26.5%
3,820,000
-11.9%
0.01%
-7.1%
Q4 2019$6,637,000
+1.5%
4,334,000
-9.2%
0.01%
-6.7%
Q3 2019$6,537,000
+4.3%
4,774,000
-0.0%
0.02%
+7.1%
Q2 2019$6,266,000
+31.4%
4,775,000
+35.3%
0.01%
+27.3%
Q1 2019$4,768,000
+14.4%
3,528,000
+1.0%
0.01%0.0%
Q4 2018$4,168,000
-45.4%
3,492,000
-22.0%
0.01%
-31.2%
Q3 2018$7,633,000
-46.4%
4,478,000
-54.6%
0.02%0.0%
Q2 2018$14,228,0009,858,0000.02%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ayrton Capital LLC 4,000,000$5,264,0006.84%
TENOR CAPITAL MANAGEMENT Co., L.P. 45,447,000$60,277,0001.18%
CSS LLC/IL 21,651,000$28,506,0001.03%
SHENKMAN CAPITAL MANAGEMENT INC 4,166,000$5,528,0000.70%
Weiss Asset Management LP 24,175,000$31,790,0000.66%
MACKAY SHIELDS LLC 36,316,000$47,889,0000.42%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 15,000,000$19,650,0000.25%
MIZUHO SECURITIES USA LLC 1,042,000$1,366,0000.20%
WOLVERINE ASSET MANAGEMENT LLC 13,230,000$17,384,0000.17%
D. E. Shaw & Co., Inc. 38,635,000$50,796,0000.05%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders